Allergy Therapeutics PLC Stock
€0.055
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allergy Therapeutics PLC | -5.170% | -5.983% | 5.769% | 1471.429% | 155.814% | -79.779% | - |
Alliance Pharma plc | -4.570% | -6.696% | -1.415% | -24.685% | 3.465% | -64.576% | - |
Beximco Pharmaceuticals Ltd. GDR | - | -0.465% | -3.167% | 12.042% | -2.727% | -54.947% | 8.629% |
Cellectar BioSciences Inc. | -5.040% | -13.281% | -22.378% | 25.424% | -2.632% | -78.654% | - |
News
Can Retirees Still Trust AT&T's 5.8% Dividend Yield?
U.S. wireless carrier AT&T (NYSE: T) is a polarizing stock among investors. Shares are down nearly 30% in price over the past decade, which is a tough pill to swallow. However, include AT&T's famous
Want $1,000 in Dividend Income? Here's How Much You'd Need to Invest in AT&T to Get It
A high-yielding stock can be a valuable asset in your portfolio because it can generate a lot of recurring income. Investors can often find great dividend stocks in the telecom sector, where
If You'd Invested $10,000 in AT&T Stock 20 Years Ago, Here's How Much You'd Have Today
Investing in AT&T (NYSE: T) over the past two decades has delivered mixed results for long-term investors. Let's break down what a $10,000 investment in AT&T would look like today, starting in June